FIELD: medicine.
SUBSTANCE: invention concerns PUUMALA and DOBRAVA viruses strains for preparing , vaccine preparations for specific prevention of hemorrhagic fever and renal syndrome (HFRS).
EFFECT: strains are replicable in a transferred renal cell culture of a VERO grivet with accumulating viral weight in the amount sufficient for preparing the vaccine preparations.
2 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING CULTURAL, POLYVALENT EPIDEMIC HAEMORRHAGIC FEVER DIAGNOSTICUM FOR INDIRECT IMMUNOFLUORESCENCE | 2010 |
|
RU2431148C1 |
| METHOD FOR PREPARING COMBINED BIVALENT, TISSUE-CULTURE, INACTIVATED, CONCENTRATED, PURIFIED VACCINE FOR PREVENTING HEMORRHAGIC FEVER AND RENAL SYNDROME | 2009 |
|
RU2445117C2 |
| VIRUS STRAIN FOR PRODUCING VACCINE DRUGS AGAINST HEMORRHAGIC FEVER WITH RENAL SYNDROME (OPTIONS) | 2018 |
|
RU2683508C1 |
| METHOD FOR PRODUCING "HANTA-N" TEST SYSTEM FOR DETERMINING SPECIFIC ACTIVITY OF VACCINE AGAINST HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2012 |
|
RU2590606C2 |
| METHOD OF OBTAINING IMMUNOENZYMATIC TEST SYSTEM FOR DETERMINATION OF EPITOPES OF ENVELOPE PROTEIN OF PUUMALA VIRUS WITH PROTECTIVE ORIENTATION IN VACCINE PREPARATIONS AGAINST HAEMORRHAGIC FEVER WITH RENAL SYNDROME | 2013 |
|
RU2565543C2 |
| METHOD OF PRODUCTION OF RECOMBINANT ANTIGEN G2 OF HANTAVIRUS DOBRAVA IN CELLS OF E coli | 2011 |
|
RU2495938C2 |
| STRAIN OF VIRUS OF HEMORRHAGIC FEVER WITH KIDNEY SYNDROME OF 2ND SEROTYPE FOR SPECIFIC LABORATORY DIAGNOSTICS | 0 |
|
SU1319554A1 |
| STRAIN OF VIRUS OF HEMORRHAGIC FEVER WITH RHENAL SYNDROME, USED FOR SPECIFIC LABORATORY DIAGNOSIS | 0 |
|
SU1319555A1 |
| METHOD FOR PREPARING GERMAN MEASLES VIRUS ADAPTED TO QUAIL EMBRYO FIBROBLAST | 2001 |
|
RU2213776C2 |
| METHOD OF CHANTA-VIRUS DIAGNOSTICUM PREPARING | 2000 |
|
RU2180754C2 |
